BioTrillion

BioTrillion leverages AI-powered computer vision to transform smartphones into health monitoring devices, enabling early detection of diseases through digital biomarkers—Anyone, Anywhere, Anytime.

• Commercial Partnerships: Secured our first commercial partnership with a leading pharmaceutical company, advancing from R&D to the commercialization phase.

• Clinical Validation: Our platform is clinically validated on humans with 91% average accuracy for all our biomarkers.

• Industry Recognition: Highlighted by NVIDIA (Technology), Roche (Healthcare), ARPA-H (Government), and other leaders across private and public sectors for our groundbreaking work in digital health.

Current healthcare systems fail to monitor health continuously, leaving a critical gap in early disease detection and intervention. Traditional methods are confined to clinical settings, capturing only sporadic snapshots of a persons health journey.

This gap leaves patients vulnerable to undetected, early-stage diseases, particularly outside medical environments where early intervention could be most effective.

Our platform, BioEngine4D™, utilizes AI-powered computer vision to analyze vital signs through a simple 10-second smartphone video - without the need for any additional hardware.

This technology captures early signs of neurological and cardiovascular diseases by measuring key digital biomarkers such as:
• Heart Rate
• Blood Pressure
• Pupil Dilation
• Hand Tremor
• Eye Swelling
• Skin Defects
• More...

By making health monitoring accessible—Anyone, Anywhere, Anytime—we aim to democratize healthcare and empower individuals to take control of their well-being.

Our business model is designed to be simple, scalable, and adaptable across multiple markets:
• Per Scan
• Per Month (SaaS)
• Exclusive Licensing

We operate on a B2B and B2B2C model, with markets including:
• Providers: Integrating advanced health monitoring capabilities for Telehealth 2.0
• Pharma: decentralized clinical trials and drug development with real-time data
• Payors: Improving risk assessment and personalized healthcare plans

• IBM Accelerator
• Microsoft for Startups
• NVIDIA Inception Program
• Amazon Web Services (AWS) Activate
• ARPA-H (Advanced Research Projects Agency for Health)

Highlights:
• IBM and NVIDIA have expressed tremendous confidence in BioTrillion, mobilizing resources to accelerate our path to market.
• NVIDIA recently featured us in an article stating: “Herbst [Head of NVIDIA’s Business Development] calls out BioTrillion as one to watch.”